--------------------------
                                                          OMB APPROVAL
                                                      OMB Number: 3235-0145
                                                      Expires: February 28, 2009
                                                      Estimated average burden
                                                      hours per response...10.4
                                                      --------------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13G/A
                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
				(Amendment No. 2)*
                                


                            Aviragen Therapeutics, Inc.
 -------------------------------------------------------------------------------
                                (Name of Issuer)

                                   COMMON STOCK
 -------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    
				    053761102

          ------------------------------------------------------------
                                 (CUSIP Number)

                               December 31, 2017
          ------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE
IS FILED:

[ ] RULE 13D-1(B)

[X] RULE 13D-1(C)

[ ] RULE 13D-1(D)

     *THE REMAINDER OF THIS COVER PAGE SHALL BE FILLED OUT FOR A REPORTING
PERSON'S INITIAL FILING ON THIS FORM WITH RESPECT TO THE SUBJECT CLASS OF
SECURITIES, AND FOR ANY SUBSEQUENT AMENDMENT CONTAINING INFORMATION WHICH 
WOULD ALTER DISCLOSURES PROVIDED IN A PRIOR COVER PAGE.

     THE INFORMATION REQUIRED ON THE REMAINDER OF THIS COVER PAGE SHALL NOT 
BE DEEMED TO BE "FILED" FOR THE PURPOSE OF SECTION 18 OF THE SECURITIES
EXCHANGE ACT OF 1934 (THE "ACT") OR OTHERWISE SUBJECT TO THE LIABILITIES 
OF THAT SECTION OF THE ACT BUT SHALL BE SUBJECT TO ALL OTHER PROVISIONS 
OF THE ACT (HOWEVER, SEE THE NOTES).


                               Page 1 of 8 Pages


<PAGE>




CUSIP NO. 053761102
          ---------

- --------------------------------------------------------------------------
  1      NAMES OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

         Krensavage Partners, L.P. 
- --------------------------------------------------------------------------
  2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [X]

(b) [ ]

- --------------------------------------------------------------------------
  3      SEC USE ONLY

- --------------------------------------------------------------------------
  4      CITIZENSHIP OR PLACE OF ORGANIZATION


          Delaware
- --------------------------------------------------------------------------
                           5    SOLE VOTING POWER

           NUMBER OF                 NONE
            SHARES
          BENEFICIALLY     -------------------------------------------------
           OWNED BY        6    SHARED VOTING POWER
             EACH
           REPORTING                2,292,058
            PERSON         -------------------------------------------------
             WITH          7    SOLE DISPOSITIVE POWER

                                     NONE
                           -------------------------------------------------
                           8    SHARED DISPOSITIVE POWER

                                    2,292,058
- --------------------------------------------------------------------------
  9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                                    2,292,058
- --------------------------------------------------------------------------
  10    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 
        [ ] (SEE INSTRUCTIONS)

- --------------------------------------------------------------------------
  11    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9   5.93%

- --------------------------------------------------------------------------
  12    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
             PN
- --------------------------------------------------------------------------

                                Page 2 of 8 Pages

<PAGE>



CUSIP NO. 053761102
          ---------

- --------------------------------------------------------------------------
  1      NAMES OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

         Krensavage Partners Too, L.P.
- --------------------------------------------------------------------------
  2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [X]
 
(b) [ ]


- --------------------------------------------------------------------------
  3      SEC USE ONLY

- --------------------------------------------------------------------------
  4      CITIZENSHIP OR PLACE OF ORGANIZATION

          Delaware
- --------------------------------------------------------------------------
                           5    SOLE VOTING POWER

           NUMBER OF                NONE
            SHARES
          BENEFICIALLY     -------------------------------------------------
           OWNED BY        6    SHARED VOTING POWER
             EACH
           REPORTING                517,473
            PERSON         -------------------------------------------------
             WITH          7    SOLE DISPOSITIVE POWER

                                     NONE
                           -------------------------------------------------
                           8    SHARED DISPOSITIVE POWER

                                    517,473
- --------------------------------------------------------------------------
  9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                                    517,473
- --------------------------------------------------------------------------

  10    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
        [ ]  (SEE INSTRUCTIONS)

- --------------------------------------------------------------------------
  11    PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9   1.34%

- --------------------------------------------------------------------------
  12    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
             PN
- --------------------------------------------------------------------------
                                Page 3 of 8 Pages

<PAGE>




CUSIP NO. 053761102
          ---------

- --------------------------------------------------------------------------
  1      NAMES OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

           Krensavage Asset Management, LLC
- --------------------------------------------------------------------------
  2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [X]
 
(b) [ ]

- --------------------------------------------------------------------------
  3      SEC USE ONLY

- --------------------------------------------------------------------------
  4      CITIZENSHIP OR PLACE OF ORGANIZATION

          Delaware 
- --------------------------------------------------------------------------
                           5    SOLE VOTING POWER

           NUMBER OF                NONE
            SHARES
          BENEFICIALLY     -------------------------------------------------
           OWNED BY        6    SHARED VOTING POWER
             EACH
           REPORTING               2,809,531
            PERSON         -------------------------------------------------
             WITH          7    SOLE DISPOSITIVE POWER

                                    NONE
                           -------------------------------------------------
                           8    SHARED DISPOSITIVE POWER

                                   2,809,531
- --------------------------------------------------------------------------
  9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                                   2,809,531
- --------------------------------------------------------------------------
  10    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 
        [ ] (SEE INSTRUCTIONS) 

- --------------------------------------------------------------------------
  11    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9    7.27%

- --------------------------------------------------------------------------
  12    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
             CO
- --------------------------------------------------------------------------

                                Page 4 of 8 Pages

<PAGE>




CUSIP NO. 053761102
          ---------

- --------------------------------------------------------------------------



ITEM 1(A)         NAME OF ISSUER:

                  Avirgen Therapeutics, Inc.

ITEM 1(B)         ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

                  2500 Northwinds Parkway, Suite 100 
                  Alpharetta, GA 30009

ITEM 2(a)         NAME OF PERSON FILING: 

                  (i) Krensavage Partners, LP (KP) with respect to
                      shares of Common Stock directly owned by it.

                 (ii) Krensavage Partners Too, LP (KPT) with respect
                      to shares of Common Stock directly owned by it.

                (iii) Krensavage Asset Management, LLC (KAM) with respect
                      to shares of Common Stock beneficially owned by it.
                      

                  
                      

                  
                      
                      
                      

                      The foregoing persons are hereinafter sometimes
                 collectively referred to as the Reporting Persons. Any 
                 disclosures herein with respect to persons other than the 
                 Reporting Persons are made on information and believe after
                 making inquiry to the appropriate party. 


ITEM 2(b)        ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE:

                 The address of the business office of each of the Reporting
                 Persons is 610 Fifth Avenue, Suite 301 New York, NY 10020
                 
ITEM 2(c)        CITIZENSHIP:

                 KP and KPT are limited partnerships organized under the
                 laws of the State of Delaware. KAM is a Delaware  
                 corporation. 
                 
                 

ITEM 2(d)         TITLE OF CLASS OF SECURITIES:

                  Common Stock

                                Page 5 of 8 Pages


<PAGE>


ITEM 2(e)         CUSIP NUMBER:

                  053761102 

ITEM 3.           IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13D-1(B) OR SS.
                  240.13d-2(B) or (C), CHECK WHETHER THE PERSON FILING IS A: 
                  
        (a) [ ] Broker or dealer registered under section 15 of the Act (15
                U.S.C. 78o).

        (b) [ ] Bank as defined in section 3(a)(6) of the Act 
                (15 U.S.C. 78c).

        (c) [ ] Insurance company as defined in section 3(a)(19) of the Act
                (15 U.S.C. 78c).

        (d) [ ] Investment company registered under section 8 of the 
                Investment Company Act of 1940 (15 U.S.C. 80a-8).

        (e) [X] An investment adviser in accordance with 
                ss.240.13d-1(b)(1)(ii)(E);
               
        (f) [ ] An employee benefit plan or endowment fund in accordance with
                ss.240.13d-1(b)(1)(ii)(F);

        (g) [ ] A parent holding company or control person in accordance with
                ss.240.13d-1(b)(1)(ii)(G);

        (h) [ ] A savings associations as defined in Section 3(b) of the
                Federal Deposit Insurance Act (12 U.S.C. 1813);

        (i) [ ] A church plan that is excluded from the definition of an
                investment company under section 3(c)(14) of the Investment 
                Company Act of 1940 (15 U.S.C. 80a-3);

        (j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J).

                                Page 6 of 8 Pages


<PAGE>

ITEM 4. OWNERSHIP:

        This Statement is being filed with respect to an aggregate of
        2,809,531 shares of Common Stock, resulting in beneficial ownership
        as follows:
        

        1. Krensavage Partners, L.P.,
           (a) Amount Beneficially owned: 2,292,062
           (b) Percent of Class: 5.93%
               The percentages used herein and in the rest of Item 4 are
               calculated based on 38,649,237 shares of Common Stock
               outstanding as of February 5, 2018, as disclosed in the
               Issuers most recent Quarterly Report on Form 10-Q for the
               quarter ended December 31, 2017, as filed with the
               SEC on February 6, 2018.
           (c) (i) Sole power to vote or direct the vote: -0-
              (ii) Shared power to vote or direct the vote: 2,292,062
             (iii) Sole power to dispose or direct the disposition: -0-
              (iv) Shared power to dispose or direct the disposition:2,292,062

        2. Krensavage Partners Too, L.P.
           (a) Amount Beneficially owned: 517,473
           (b) Percent of Class: 1.34%         
           (c) (i) Sole power to vote or direct the vote: -0-
              (ii) Shared power to vote or direct the vote: 517,473
             (iii) Sole power to dispose or direct the disposition: -0-
              (iv) Shared power to dispose or direct the disposition: 517,473

        3. Krensavage Asset Management, LLC
           (a) Amount Beneficially owned: 2,809,531
           (b) Percent of Class: 7.27%        
           (c) (i) Sole power to vote or direct the vote: -0-
              (ii) Shared power to vote or direct the vote:2,809,531
             (iii) Sole power to dispose or direct the disposition: -0-
              (iv) Shared power to dispose or direct the disposition:
                   2,809,531

                                Page 7 of 8 Pages


<PAGE>        

ITEM 5.         OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

                  N/A

ITEM 6.         OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER 
                PERSON.

                As the discretionary investment manager of the KP and KPT LP's
		KAM has power to direct the voting and disposition of
                shares held by KP and KPT LP's.  
                               

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
        THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR
        CONTROL PERSON.

                  N/A


ITEM 8.           IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.


                  See Item 2. 


ITEM 9.           NOTICE OF DISSOLUTION OF GROUP.

                  N/A

                  
                                Page 8 of 8 Pages


<PAGE>

ITEM 10.          CERTIFICATION.

                  By signing below I certify that, to the best of my 
knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that
purpose or effect.


                                    SIGNATURE

                  After reasonable inquiry and to the best of my knowledge 
and belief, I hereby certify that the information set forth in this statement
is true, complete and correct.

February 9, 2018
                                              /s/ Louis A. Parks 
                                              ----------------------------------
                                              Chief Compliance Officer
					      Krensavage Asset Management, LLC